Company Data
Prelude Therapeutics Incorporated
Ticker
PRLD
Current Price
$0.8709 -3.5%
Market Cap
$47.9M
Price Target
Refer to Report
Volume
161.1K
52wk Range
$0.7966 - $6.8
Overview
Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet need.